{"id":"NCT00328653","sponsor":"Santen SAS","briefTitle":"Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)","officialTitle":"Phase II/III, Multicenter, Double-Masked, Randomized, Parallel Group, Dose Ranging, Controlled Trial of Efficacy and Tolerance of Nova22007 (Cyclosporine A [CSA] 0.05% & 0.1% Ophthalmic Cationic Emulsion) Versus Vehicle in Patients With VKC","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-05","primaryCompletion":"2007-02-22","completion":null,"firstPosted":"2006-05-22","resultsPosted":"2021-12-14","lastUpdate":"2021-12-14"},"enrollment":118,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":null},"conditions":["Conjunctivitis, Vernal"],"interventions":[{"type":"DRUG","name":"Cyclosporine NOVA22007 0.05%","otherNames":[]},{"type":"DRUG","name":"Cyclosporine NOVA22007 0.1%","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"NOVA22007 0.05%","type":"EXPERIMENTAL"},{"label":"NOVA22007 0.1%","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"SHAM_COMPARATOR"}],"summary":"The primary objective of this study is:\n\n* To assess the efficacy of Nova22007, a cyclosporine A (CsA), 0.05% and 0.1% versus vehicle in patients with vernal keratoconjunctivitis (VKC) after a 4-week treatment period.\n\nThe secondary objectives of this study are:\n\n* To compare the safety and ocular tolerance of Nova22007 0.05% and 0.1%;\n* To assess the long term safety and ocular tolerance of Nova22007 0.05% and 0.1%; and\n* To assess the decrease in frequency of concomitant artificial tears use.","primaryOutcome":{"measure":"Overall Rating of Subjective Symptoms of VKC in Period I","timeFrame":"Week 4","effectByArm":[{"arm":"Vehicle","deltaMin":7,"sd":null},{"arm":"NOVA22007 0.05%","deltaMin":1,"sd":null},{"arm":"NOVA22007 0.1%","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2699"},{"comp":"OG000 vs OG002","p":"0.2719"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":["37872059"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["Allergic keratitis","Instillation site pruritus","Instillation Site Irritation","Visual acuity reduced","Drug intolerance"]}}